Because our data lead to tempering the reliability of basing individualization of the starting age of preventive measures on family history, they also emphasize the need for refining the understanding of phenotype variability of BRCA1/2 cancer-susceptibility hereditary syndrome. The gene discussed is BRCA1; the disease is cancer.